Methods This was a population-based retrospective cohort study conducted using TriNetX
(Cambridge, MA), a federated health research network data set. We performed a real-time …

Background Accurate estimates for the risk of COVID‐19 in IBD, and an understanding of the
impact of COVID‐19 on IBD course and the risk of incident post‐infectious IBD are needed …

Methods We performed a retrospective analysis of consecutive patients whose SARS-CoV-2
testing was performed at Stanford between March 04, 2020, and April 14, 2020. California …

Background and Aims. The impact of COVID‐19 has been of great concern in patients with
inflammatory bowel disease (IBD) worldwide, including an increased risk of severe …

Abstract Background and Aims As no population-based study has investigated the
susceptibility and disease course of COVID-19 among patients with inflammatory bowel …

Objective Our aim was to explore the risk of infection with all classes of inflammatory bowel
disease (IBD) medications and the impact of these medications on the disease course in a …

Background Our understanding of coronavirus disease 2019 (COVID-19) and its
implications for patients with inflammatory bowel diseases (IBD) is rapidly evolving. We …

Abstract Background and Aims The COVID-19 risk and disease course in inflammatory
bowel disease [IBD] patients remains uncertain. Therefore, we aimed to assess the clinical …

Abstract Background and Aims Age is a major prognostic factor for COVID-19 outcomes. The
effect of inflammatory bowel disease [IBD] activity on COVID-19 is unclear. We examined the …

Baseline Disease Activity and Steroid Therapy Stratify Risk of COVID-19 in Patients With
Inflammatory Bowel Disease - Gastroenterology Skip to Main Content Advertisement …